No abstract available
MeSH terms
-
Adenine / analogs & derivatives
-
Agammaglobulinaemia Tyrosine Kinase
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Antineoplastic Agents / therapeutic use*
-
Benzylamines
-
Chemokine CXCL12 / genetics
-
Chemokine CXCL12 / metabolism
-
Class I Phosphatidylinositol 3-Kinases / antagonists & inhibitors
-
Class I Phosphatidylinositol 3-Kinases / genetics
-
Class I Phosphatidylinositol 3-Kinases / metabolism
-
Cyclams
-
Gene Expression Regulation, Neoplastic*
-
Genetic Heterogeneity
-
Heterocyclic Compounds / therapeutic use
-
Humans
-
Immunoglobulin Heavy Chains / genetics*
-
Immunoglobulin Heavy Chains / metabolism
-
Integrin alpha4 / genetics*
-
Integrin alpha4 / metabolism
-
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
-
Leukemia, Lymphocytic, Chronic, B-Cell / genetics
-
Leukemia, Lymphocytic, Chronic, B-Cell / mortality
-
Leukemia, Lymphocytic, Chronic, B-Cell / pathology
-
Mutation
-
Natalizumab
-
Piperidines
-
Prognosis
-
Protein-Tyrosine Kinases / antagonists & inhibitors
-
Protein-Tyrosine Kinases / genetics
-
Protein-Tyrosine Kinases / metabolism
-
Purines / therapeutic use
-
Pyrazoles / therapeutic use
-
Pyrimidines / therapeutic use
-
Quinazolinones / therapeutic use
-
Receptors, CXCR4 / antagonists & inhibitors
-
Receptors, CXCR4 / genetics*
-
Receptors, CXCR4 / metabolism
-
Signal Transduction
-
Survival Analysis
Substances
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
Benzylamines
-
CXCL12 protein, human
-
CXCR4 protein, human
-
Chemokine CXCL12
-
Cyclams
-
Heterocyclic Compounds
-
Immunoglobulin Heavy Chains
-
Natalizumab
-
Piperidines
-
Purines
-
Pyrazoles
-
Pyrimidines
-
Quinazolinones
-
Receptors, CXCR4
-
Integrin alpha4
-
ibrutinib
-
Class I Phosphatidylinositol 3-Kinases
-
PIK3CD protein, human
-
Protein-Tyrosine Kinases
-
Agammaglobulinaemia Tyrosine Kinase
-
BTK protein, human
-
Adenine
-
plerixafor
-
idelalisib